{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:04:54Z","timestamp":1759565094150},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,20]],"date-time":"2010-04-20T00:00:00Z","timestamp":1271721600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00404-010-1464-7","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T05:17:24Z","timestamp":1271654244000},"page":"611-616","source":"Crossref","is-referenced-by-count":4,"title":["Expression of p16 protein and epidermal growth factor receptor in patients with adenocarcinoma of the uterine cervix: an immunohistochemical analysis"],"prefix":"10.1007","volume":"283","author":[{"given":"Klaus","family":"Bodner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Laubichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Kimberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Czerwenka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Zeillinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bodner-Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,20]]},"reference":[{"key":"1464_CR1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2003.09.001","volume":"92","author":"A Baalbergen","year":"2004","unstructured":"Baalbergen A, Ewing-Graham PC, Hop WCJ, Striujk P, Helmerhorst TH (2004) Prognostic factors in adenocarcinoma of the uterine cervix. Gynecol Oncol 92:262\u2013267","journal-title":"Gynecol Oncol"},{"key":"1464_CR2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0046-8177(97)90003-4","volume":"28","author":"JA Cohen","year":"1997","unstructured":"Cohen JA, Geradts J (1997) Loss of RB and MTS1\/CDKN2 (p16) expression in human sarcomas. Hum Pathol 28:893\u2013898","journal-title":"Hum Pathol"},{"key":"1464_CR3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","volume":"264","author":"A Kamb","year":"1994","unstructured":"Kamb A, Gruis NA, Weaver-Feldhaus J et al (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington, DC) 264:436\u2013440","journal-title":"Science (Washington, DC)"},{"key":"1464_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.1998.5134","volume":"71","author":"YT Kim","year":"1998","unstructured":"Kim YT, Cho NH, Park SW, Kim JW (1998) Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma. Gynecol Oncol 71:38\u201345","journal-title":"Gynecol Oncol"},{"key":"1464_CR5","first-page":"3396","volume":"54","author":"T Mori","year":"1994","unstructured":"Mori T, Miura K, Nishihara T, Mori S, Nakamura Y (1994) Frequent somatic mutation of the MTS\/CDK41 gene in esophageal squamous cell carcinoma. Cancer Res 54:3396\u20133397","journal-title":"Cancer Res"},{"key":"1464_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng0994-27","volume":"8","author":"C Caldas","year":"1994","unstructured":"Caldas C, Hahn SA, DaCosta LT et al (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8:27\u201332","journal-title":"Nat Genet"},{"key":"1464_CR7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0090-8258(03)00010-6","volume":"89","author":"G Putte Van de","year":"2003","unstructured":"Van de Putte G, Holm R, Lie AK, Trope CG, Kristensen GB (2003) Expression of p27, p21 and p16 protein in early squamous cervical cancer and its relation to prognosis. Gynecol Oncol 89:140\u2013147","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1464_CR8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.5149","volume":"264","author":"JW Rocco","year":"2001","unstructured":"Rocco JW, Sidransky D (2001) p16 (MTS-1\/CDKN2\/INK4a) in cancer progression. Exp Cell Res 264(1):42\u201355","journal-title":"Exp Cell Res"},{"issue":"2","key":"1464_CR9","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","volume":"92","author":"R Klaes","year":"2001","unstructured":"Klaes R, Friedrich T, Spitkovsky D et al (2001) Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic cells of the cervix uteri. Int J Cancer 92(2):276\u2013284","journal-title":"Int J Cancer"},{"issue":"8","key":"1464_CR10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1440-1827.1998.tb03954.x","volume":"48","author":"T Sano","year":"1998","unstructured":"Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima J (1998) Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int 48(8):580\u2013585","journal-title":"Pathol Int"},{"key":"1464_CR11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/j.1460-2075.1995.tb07026.x","volume":"14","author":"D Parry","year":"1995","unstructured":"Parry D, Bates S, Mann DJ et al (1995) Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4\/MTS1 tumour suppressor gene product. EMBO J 14:503\u2013511","journal-title":"EMBO J"},{"issue":"10","key":"1464_CR12","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/bjc.1997.243","volume":"75","author":"Y Nakao","year":"1997","unstructured":"Nakao Y, Yang X, Yokoyama M et al (1997) Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer 75(10):1410\u20131416","journal-title":"Br J Cancer"},{"issue":"11","key":"1464_CR13","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","volume":"26","author":"R Klaes","year":"2002","unstructured":"Klaes R, Benner A, Friedrich T et al (2002) p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26(11):1389\u20131399","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1464_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2009.06.020","volume":"115","author":"F Kurshumliu","year":"2009","unstructured":"Kurshumliu F, Thorns C, Gashi-Luci L (2009) p16INK4A in routine practice as a marker of cervical epithelial neoplasia. Gynecol Oncol 115(1):127\u2013131","journal-title":"Gynecol Oncol"},{"issue":"12","key":"1464_CR15","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2409::AID-CNCR15>3.0.CO;2-T","volume":"82","author":"X Lu","year":"1998","unstructured":"Lu X, Toki T, Konishi I, Nikaido T, Fujii S (1998) Expression of p21WAF1\/CIP1 in adenocarcinoma of the uterine cervix. A possible marker of a favourable prognosis. Cancer 82(12):2409\u20132417","journal-title":"Cancer"},{"issue":"9","key":"1464_CR16","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/cncr.11727","volume":"98","author":"GC Alfsen","year":"2003","unstructured":"Alfsen GC, Reed W, Sandstad B, Kristensen GB, Abeler VM (2003) The prognostic impact of the cyclin dependent kinase inhibitors p16WAF1, p27KIP1, and p16 INK4\/MTS1 in adenocarcinomas of the uterine cervix. An immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma. Cancer 98(9):1880\u20131889","journal-title":"Cancer"},{"issue":"4","key":"1464_CR17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.pgp.0000092135.88121.1f","volume":"22","author":"M Ishikawa","year":"2003","unstructured":"Ishikawa M, Fujii T, Masumoto N et al (2003) Correlation of p16INK4A overexpression with human papillomavirus infection in cervical adenocarcinomas. Int J Gynecol Pathol 22(4):378\u2013385","journal-title":"Int J Gynecol Pathol"},{"key":"1464_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0303-7207(90)90211-P","volume":"70","author":"TJ Velu","year":"1990","unstructured":"Velu TJ (1990) Structure, function and transforming potential of the epidermal growth factor receptor. Mol Cell Endocrinol 70:205\u2013216","journal-title":"Mol Cell Endocrinol"},{"key":"1464_CR19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ygyno.2007.04.019","volume":"106","author":"F Cerciello","year":"2007","unstructured":"Cerciello F, Riesterer O, Sherweif M, Odermatt B, Ciernik IF (2007) Is EGFR a moving target during radiotherapy of carcinoma of the uterine cervix? Gynecol Oncol 106:394\u2013399","journal-title":"Gynecol Oncol"},{"key":"1464_CR20","first-page":"3","volume":"13","author":"JGM Klijn","year":"1992","unstructured":"Klijn JGM, Berns PMJ, Schmitz PIM, Foekens AJ (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev 13:3\u201317","journal-title":"Endocr Rev"},{"key":"1464_CR21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ijc.2910560106","volume":"56","author":"G Scambia","year":"1994","unstructured":"Scambia G, Benedetti-Panici P, Ferrandina G et al (1994) Significance of epidermal growth factor receptor expression in primary human endometrial cancer. Int J Cancer 56:26\u201330","journal-title":"Int J Cancer"},{"key":"1464_CR22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bjc.1995.339","volume":"72","author":"G Scambia","year":"1995","unstructured":"Scambia G, Benedetti-Panici P, Ferrandina G et al (1995) Epidermal growth factor, oestrogen and progesterone receptor expression in primary ovarian cancer: correlation with clinical outcome and response to chemotherapy. Br J Cancer 72:361\u2013366","journal-title":"Br J Cancer"},{"key":"1464_CR23","first-page":"267","volume":"4","author":"G Altavilla","year":"1996","unstructured":"Altavilla G, Castellan L, Wabersich J, Marchetti M, Onnis A (1996) Prognostic significance of epidermal growth factor receptor (EGFR) and c-erbB-2 protein overexpression in adenocarcinoma of the uterine cervix. Eur J Gynaecol Oncol 4:267\u2013270","journal-title":"Eur J Gynaecol Oncol"},{"key":"1464_CR24","first-page":"1159","volume":"8","author":"T Leung","year":"2001","unstructured":"Leung T, Cheung A, Cheng D, Wong L, Ngan H (2001) Expressions of c-erbB-2, epidermal growth factor receptor and pan-ras proto-oncogenes in adenocarcinoma of the cervix: correlation with clinical prognosis. Oncol Rep 8:1159\u20131164","journal-title":"Oncol Rep"},{"issue":"7","key":"1464_CR25","first-page":"2577","volume":"29","author":"AK Lindstroem","year":"2009","unstructured":"Lindstroem AK, Tot T, Stendahl U, Syrjaenen S, Syrjaenen K, Hellberg D (2009) Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer. Anticancer Res 29(7):2577\u20132578","journal-title":"Anticancer Res"},{"issue":"3","key":"1464_CR26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/pgp.0b013e31802f1996","volume":"26","author":"F Baltazar","year":"2007","unstructured":"Baltazar F, Filho AL, Pinheiro C et al (2007) Cyclooxygenase-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas. Int J Gynecol Pathol 26(3):235\u2013241","journal-title":"Int J Gynecol Pathol"},{"key":"1464_CR27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. Am J Stat Ass 53:457\u2013481","journal-title":"Am J Stat Ass"},{"key":"1464_CR28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1006\/gyno.1996.0039","volume":"60","author":"JW Kim","year":"1996","unstructured":"Kim JW, Kim YT, Kim DK, Song CH, Lee JW (1996) Expression of epidermal growth factor receptor in carcinoma of the cervix. Gynecol Oncol 60:283\u2013287","journal-title":"Gynecol Oncol"},{"key":"1464_CR29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ygyno.2004.01.006","volume":"93","author":"CM Lee","year":"2004","unstructured":"Lee CM, Lee RJ, Hammond E et al (2004) Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis. Gynecol Oncol 93:209\u2013214","journal-title":"Gynecol Oncol"},{"key":"1464_CR30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ygyno.2005.05.045","volume":"99","author":"CM Lee","year":"2005","unstructured":"Lee CM, Shrieve DC, Zempolich KA et al (2005) Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix. Gynecol Oncol 99:415\u2013421","journal-title":"Gynecol Oncol"},{"key":"1464_CR31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0090-8258(03)00504-3","volume":"91","author":"NH Cho","year":"2003","unstructured":"Cho NH, Kim YB, Park TK, Kim GE, Park K, Song KJ (2003) p63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma. Gynecol Oncol 91:346\u2013353","journal-title":"Gynecol Oncol"},{"issue":"4","key":"1464_CR32","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0360-3016(03)00209-8","volume":"56","author":"DK Gaffney","year":"2003","unstructured":"Gaffney DK, Haslam D, Tsodikov A et al (2003) Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int J Radiat Oncol Biol Phys 56(4):922\u2013928","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1464_CR33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/gyno.2002.6803","volume":"87","author":"YT Kim","year":"2002","unstructured":"Kim YT, Park SW, Kim JW (2002) Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma. Gynecol Oncol 87:84\u201389","journal-title":"Gynecol Oncol"},{"key":"1464_CR34","first-page":"577","volume":"5","author":"AM Kersemaekers","year":"1999","unstructured":"Kersemaekers AM, Fleuren GJ, Kenter GG et al (1999) Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. Clin Cancer Res 5:577\u2013586","journal-title":"Clin Cancer Res"},{"key":"1464_CR35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(97)00421-7","volume":"123","author":"G Scambia","year":"1998","unstructured":"Scambia G, Ferrandina G, Distefano M et al (1998) Epidermal growth factor receptor (EGFR) is not related to prognosis of cervical cancer. Cancer Lett 123:135\u2013139","journal-title":"Cancer Lett"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1464-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-010-1464-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-010-1464-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:54:03Z","timestamp":1559051643000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-010-1464-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,20]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1007\/s00404-010-1464-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,20]]}}}